Based on our previous data in bone metastases from breast cancer [22], and on the fact that bone metastases are the hallmark of progressive disease and CRPC, mainly characterized by AR alterations [23], we investigated whether and how ERRα is involved in bone progression of CRPC (AR-negative) models. The gene discussed is AR; the disease is breast cancer.